The use of molecular profiling for diagnosis and research in non-Hodgkin's lymphoma

by Miguel Angel Piris
Published 2011-10-01

Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy

by Nuria García-Díaz, Miguel Ángel Piris, Pablo Luis Ortiz‐Romero, José Pedro Vaqué
Published 2021-04-01

Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy

by Laura Tomas-Roca, Marta Rodriguez, Ruth Alonso-Alonso, Socorro M. Rodriguez-Pinilla, Miguel Angel Piris
Published 2021-05-01

An A91V SNP in the perforin gene is frequently found in NK/T-cell lymphomas.

by Rebeca Manso, Socorro María Rodríguez-Pinilla, Luis Lombardia, Gorka Ruiz de Garibay, Maria Del Mar López, Luis Requena, Lydia Sánchez, Margarita Sánchez-Beato, Miguel Ángel Piris
Published 2014-01-01

Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.

by Rufino Mondejar, Cristina Pérez, Arantza Onaindia, Nerea Martinez, Julia González-Rincón, Helena Pisonero, Jose Pedro Vaqué, Laura Cereceda, Miguel Santibañez, Margarita Sánchez-Beato, Miguel Angel Piris
Published 2017-01-01

High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.

by Lorena Maestre, Juan Fernando García-García, Scherezade Jiménez, Ana Isabel Reyes-García, Álvaro García-González, Santiago Montes-Moreno, Alberto J Arribas, Patricia González-García, Eduardo Caleiras, Alison H Banham, Miguel Ángel Piris, Giovanna Roncador
Published 2020-01-01

Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution?

by Macarena Boiza-Sánchez, Rebeca Manso, Olga Balagué, Cristina Chamizo, Elham Askari, Rocío Nieves Salgado, Carlos Blas-López, Elena Aguirregoicoa-García, Javier Menárguez, Carlos Santonja, Magdalena Adrados, Miguel Ángel Limeres-González, Miguel Ángel Piris, Socorro María Rodríguez-Pinilla
Published 2020-01-01

Compassionate use of tocilizumab in severe SARS-CoV2 pneumonia

by Miguel Górgolas Hernández-Mora, Alfonso Cabello Úbeda, Laura Prieto-Pérez, Felipe Villar Álvarez, Beatriz Álvarez Álvarez, María Jesús Rodríguez Nieto, Irene Carrillo Acosta, Itziar Fernández Ormaechea, Aws Waleed Mohammed Al-Hayani, Pilar Carballosa, Silvia Calpena Martínez, Farah Ezzine, Marina Castellanos González, Alba Naya, Marta López De Las Heras, Marcel José Rodríguez Guzmán, Ana Cordero Guijarro, Antonio Broncano Lavado, Alicia Macías Valcayo, Marta Martín García, Javier Bécares Martínez, Ricardo Fernández Roblas, Miguel Ángel Piris Pinilla, José Fortes Alen, Olga Sánchez Pernaute, Fredeswinda Romero Bueno, Sarah Heili-Frades, Germán Peces-Barba Romero
Published 2021-01-01